MedTech Terms
    The authoritative reference
    All terms

    Category III CPT Code

    Temporary CPT code for emerging technologies and services.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Category III CPT codes are temporary alphanumeric codes (ending in 'T') that track utilization of new or emerging procedures for which insufficient data exists for Category I designation. Codes sunset after five years if not converted or renewed.
    What the regulation says
    Category III CPT codes, while primarily for reimbursement tracking, indirectly influence MedTech product development and market access strategies. The Centers for Medicare & Medicaid Services (CMS) and private payers use these codes to monitor emerging technologies, helping to determine future coverage and payment policies. Although not regulatory codes themselves, their existence reflects the ongoing evaluation of new medical procedures.

    What this means in practice

    Often the first formal CPT pathway for a novel device-enabled procedure. Payment is at payer discretion; many commercial payers deny Category III claims as investigational.

    Examples

    • A MedTech company develops a novel minimally invasive surgical device. To track its clinical use, a Category III CPT code is established before sufficient long-term outcomes data is available for a Category I designation.
    • A hospital system implements a new diagnostic procedure involving an AI-powered device. A Category III CPT code facilitates the collection of utilization data, which helps in future discussions with payers regarding coverage.
    • A medical device manufacturer collaborates with clinicians to publish studies on the effectiveness of a new therapy tracked by a Category III CPT code, aiming to demonstrate its value and support its transition to a Category I code.
    Common pitfalls
    • Misinterpreting Category III CPT codes as a guarantee of reimbursement, as payment remains at payer discretion and is often denied given the 'investigational' status.
    • Failing to recognize the temporary nature of Category III CPT codes; they sunset after five years if not converted to Category I or renewed.
    • Neglecting to collect robust clinical data during the Category III phase, which is crucial for demonstrating efficacy and eventually achieving Category I CPT code status and broader reimbursement.
    • Assuming that FDA clearance or approval automatically leads to CPT codes and reimbursement; these are separate processes with distinct criteria.

    Frequently asked questions

    Category III CPT codes offer a formal pathway for tracking new procedures, which is vital for MedTech companies developing novel device-enabled treatments. They provide data necessary for pursuing broader reimbursement and market adoption, even if initial payment is limited.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    AMA·2AdvaMed·1
    1. 1
      AMA Category III process
      Verified
      AMAama-assn.org
    2. 2
      AMA CPT Resources
      Verified
      AMAama-assn.org
    3. 3
      AdvaMed - Payment & Coverage
      Verified
      AdvaMedadvamed.org

    Inline markers like [1] jump to the matching reference above.